Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced the execution of a five-year ...

Harrow (HROW) announced the execution of a five-year strategic supply and development agreement for Triesence 40 mg/mL, a preservative-free ...

Pykus Therapeutics, Inc. ("Pykus" or the "Company"), a clinical-stage medical technology company, announced today that it will present an overview of its investigational retinal sealant, PYK-2101, at ...

Shares of Harrow Inc. started Tuesday’s trading session increasing in value somewhat after the Nashville-based eyecare ...

This article will explain why eye screenings are crucial, how diabetic retinopathy develops, and what you can do to protect your vision.

Shares of Harrow Inc. saw modest movement during Tuesday’s trading session after the Nashville-based eyecare pharmaceutical company announced U.S. Food and Drug Administration approval of the ...

Engaging survivors of intimate partner violence in research brings valuable perspectives that can drive meaningful improvements in mental health services.

At close: 11 March at 5:35:02 pm GMT+1 Loading Chart for AFX.DE ...